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Accepted 11 April 2016Tonicity-responsive enhancer (TonE) binding protein (TonEBP) is known as an osmosensitive transcription fac-
tor that regulates cellular homeostasis during states of hypo- and hypertonic stress. In addition to its role in
osmoadaptation, growing lines of evidence suggest that TonEBP might have tonicity-independent functions. In
particular, a number of studies suggest that inﬂammatory stimuli induce the expression and activation of TonEBP
in peripheral immune cells. However, whether TonEBP is expressed in microglia, resident immune cells of the
central nervous system, is unknown. Here we show that inﬂammatory signals induce the expression of TonEBP
in microglia both in vitro and in vitro. In cultured primary microglia, treatment with lipopolysaccharide (LPS),
interferon-γ, and interleukin 4 increased the expression of TonEBP.Moreover,we found that stereotaxic injection
of LPS into the substantia nigra region of rat brain increased TonEBP expression in OX-42-positive cells. Further-
more, expression of TonEBPwas induced inOX-42-positive cells in a ratmodel of transientmiddle cerebral artery
occlusion. Together these results show that the expression of TonEBP is regulated by inﬂammatory signals in
mammalian brain, suggesting that TonEBP might play a part during neuroinﬂammation.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Neuroinﬂammation1. Introduction
Microglia, the resident macrophages of the central nervous system
(CNS), represent the major immune-competent cell type in the brain
(Nayak et al., 2014). Amajor role of microglia is to survey the CNS envi-
ronment and serve asﬁrst line defenders against infectious agents. Acti-
vation ofmicroglia in response to noxious stimuli triggers inﬂammatory
processes characterized by the secretion of pro-inﬂammatorymediators
and the induction of several enzymes responsible for the production oftute-Center for Neuroscience,
and Care System of Dementia,
ro 14-gil, Seongbuk-gu, Seoul
ence, Department of Physiology,
niversity School ofMedicine, 26
of Korea.
@khu.ac.kr (B.D. Lee).
. This is an open access article underreactive molecules. Fundamentally, immune system functions to pro-
tect the CNS from infection, tissue damage, or metabolic derangements,
but if the condition causing acute inﬂammation persists for a prolonged
period of time and transits to a chronic phage, neuroinﬂammation can
be detrimental and contribute to the development and progression of
a number of neurodegenerative diseases (Lee et al., 2009). Therefore,
identifying the players and molecules as well as investigating the regu-
latory mechanisms of neuroinﬂammation are of crucial importance.
Tonicity-responsive enhancer binding protein (TonEBP), also known
as nuclear factor of activated T-cells 5 (NFAT5), is an essential transcrip-
tion factor involved in the maintenance of cellular homeostasis against
hypo- or hypertonic osmotic stress (Halterman et al., 2012b;
Miyakawa et al., 1999). Hypertonic condition is known to induce
TonEBP expression, nuclear translocation and association with target
genes that control osmoadaptation. In addition to the well-
documented role of TonEBP in osmoadaptation, previous studies have
implied that TonEBP might have tonicity-independent functionsthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and development, tumor metastasis, and hepatic detoxiﬁcation
(Berga-Bolanos et al., 2010; Go et al., 2004; Halterman et al., 2012b;
Levy et al., 2010; Lopez-Rodriguez et al., 2004). Notably, tonicity-independent signals, such as inﬂammatory stimuli, have been suggested
to regulate TonEBP in several physiological and pathological conditions.
In particular, elevated expression or activation of TonEBP has been re-
ported in a number of inﬂammatory diseases including atherosclerosis,
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2012a; Yang et al., 2006; Yoon et al., 2011). In a rodentmodel of athero-
sclerosis, haploinsufﬁciency of TonEBP (TonEBP+/−) suppressed ath-
erosclerotic lesion formation, which was accompanied by impaired
macrophage migration (Yoon et al., 2011), and decreased arthritis se-
verity with limited inﬂammatory cell inﬁltration, joint destruction,
and synovial hyperplasia (Halterman et al., 2012a). These results sug-
gest that TonEBP might play a part in the regulation of inﬂammatory
functions in immune cells.
Microglia in the brain exert functions similar to that of macrophages
in the periphery. To the best of our knowledge, under both physiological
and pathological conditions, expression of TonEBP in microglia has not
been reported to date. In normal rat brain, TonEBP expression appears
to be widespread and heterogeneous (Maallem et al., 2006), but previ-
ous studies have shown that TonEBP is expressed primarily in neurons
rather than glial cells, and its localization is restricted in the nucleus.
In rats subjected to acute or prolonged systemic hypertonicity, TonEBP
expression increased in the nucleus (Loyher et al., 2004; Maallem
et al., 2006). In addition to neurons, faint nuclear labeling of TonEBP
was detected in non-neuronal cells in the brain, but only in a very
minor proportion of astrocytes and oligodendrocytes. The level in such
cells, however, did not increase in animals which received i.p. injections
of hypersonic sucrose solution to induce hypertonicity (Loyher et al.,
2004; Maallem et al., 2006). Notably, none of the TonEBP-expressing
cells stained positive for markers of microglia in both normal isotonic
animals and animals subjected to hypertonicity. In this study, we have
examined if TonEBP expression is regulated by inﬂammatory signals
in microglia both in vivo and in vitro. We found that intracranial injec-
tion of lipopolysaccharide (LPS) into the substantia nigra (SN) of rat
brain and ischemic brain injury induced by middle cerebral artery in-
farction increased TonEBP expression in microglia in vivo. In addition,
LPS as well as other inﬂammatory activators, such as interferon-γ and
interleukin 4, increased the expression of TonEBP in primary cultures
of microglia. These results suggest that in microglia, TonEBP expression
is controlled by inﬂammatory signals and might play part during
neuroinﬂammation.
2. Materials and methods
2.1. Animals
Sprague–Dawley rats (SD rat, 8-weeks-old) were acclimatized for
1week under conditions of controlled temperature (22± 2 °C), constant
humidity, and a 12-h light/dark cycle, and food and water were made
available ad libitum. All surgical procedures were conducted according
to the animal welfare guidelines approved by the Kyung Hee University
Institutional Animal Care and Use Committee (KHUASP(SE)-12-027).
2.2. Rat stereotaxic surgery
Female Sprague Dawley (SD) rats (230–280 g)were anesthetized by
injection of chloral hydrate (400mg/kg, i.p.), positioned in a stereotaxic
apparatus and received a unilateral administration of phosphate buff-
ered saline (PBS) or LPS (5 μg in 3 μl of PBS; Sigma-Aldrich) into the
right SN (anteroposterior (AP) 5.1 mm, mediololateral (ML) 2.0 mm,
dorsoventral (DV) 7.9 mm from bregma), according to the atlas ofFig. 1. LPS induces TonEBP expression in OX-42-positive cells in vivo. PBS or LPS (5 μg in 3 μl of P
were removed and sectioned for immunostaining, as described in the Materials andmethods. T
and rabbit immunoglobulin (IgG) (B), anti-NeuN and anti-TonEBP antibodies (C), or anti-GFAP
speciﬁcally in the nucleus of OX-42-positive cells. In both PBS- and LPS-injected brain sections
animals were tested and similar results were obtained in all animals examined. Scale bar,
contralateral side of LPS (LPS, lower panels) or ipsilateral side of PBS (PBS, upper panels) injec
with LPS or PBS. Cells expressing TonEBP in OX-42+ or NeuN+ cells were counted and values
of the contralateral side. Note that the number of TonEBP+ cells markedly increases in OX-4
signal in NeuN+ cells. SN sections from rats injected with PBS or LPS were immunostained w
cells. *** p b 0.001; Student's t-test versus contralateral side of PBS injection.Paxinos and Watson (2005). All injections were performed by using a
Hamilton syringe equipped with a 30 s gauge beveled needle attached
to a syringe pump (KD Scientiﬁc, MA, USA). Infusions were performed
at a rate of 0.5 μl/min for LPS or PBS as a control. After injection, animals
were euthanized by cervical dislocation and brains were harvested at
indicated time points.
2.3. Focal cerebral ischemia rat model induction and treatment
Focal cerebral ischemiawas induced byMCAousing the intraluminal
suture method, as described elsewhere (Lee et al., 2012). Brieﬂy, rats
were anesthetizedwith isoﬂurane in N2O andO2 (70:30). MCAowas in-
duced by inserting sutures (360 μm in thicknesses; Doccol Co., NM,
USA) 19–20mm from the bifurcation of the internal and external carot-
id arteries for 2 h. Reperfusionwas achieved by retracting the sutures. In
the sham-operated group, rats were subjected to identical procedure,
except for the probe insertion length (10 mm). Rectal temperatures
were monitored and controlled throughout surgery (37 ± 0.5 °C).
Brains were dissected at 24 h after MCAo.
2.4. Tissue preparation
Animals were transcardially perfusedwith a saline solution contain-
ing 0.5% sodium nitrate and heparin (10 U/ml) and then ﬁxed with 4%
paraformaldehyde dissolved in 0.1 M phosphate buffer. Brains were re-
moved from the skull, postﬁxed overnight in buffered 4% paraformalde-
hyde at 4 °C, stored in a 30% sucrose solution at 4 °C until they sank, and
were frozen sectioned on a sliding microtome to 30 μm-thick coronal
sections. At least four sections per animal were tested and all sections
were collected and processed for immunostaining, as described previ-
ously (Chung et al., 2012).
2.5. Double immunoﬂuorescence staining
For double-immunoﬂuorescence staining, tissue sectionswere proc-
essed as described elsewhere (Park et al., 2007). Brieﬂy, sections were
collected in PBS and sections were incubated in 0.2% Triton X-100 for
30min and rinsed three timeswith 0.5% BSA. The sectionswere then in-
cubated with the indicated primary antibodies (rabbit anti-TonEBP
(Miyakawa et al., 1999), 1:1000; mouse anti-OX-42, 1:400 (Serotec,
UK); mouse anti-NeuN, 1:1000 (Millipore, US); mouse anti-GFAP
1:1500 (Abcam, US)) overnight at 4 °C. After washing in PBS, the sec-
tions were incubated with secondary antibodies (FITC-conjugated rab-
bit anti-rat IgG, 1:1000; Texas Red-conjugated donkey anti-goat IgG,
1:1000 (Abcam, USA)) for 1 h at room temperature. Floating sections
were mounted on gelatin-coated slides and dried for 1 h at room tem-
perature. Slides were mounted by adding Vectashield medium (Vector
Laboratories). Slides were imaged by using an LSM 700 confocal laser
scanning microscope (Carl Zeiss, Germany).
2.6. Mesencephalic microglia culture
Primary microglia were prepared from the ventral mesencephalons
of embryonic 14 day brains of SD rats, as described elsewhere (Kim
et al., 2000) with some modiﬁcations. Brieﬂy, tissues were triturated
and dissociated cells were plated into 75-cm2 T-ﬂasks pre-coated withBS) was injected unilaterally into the SN. After three days, rats were sacriﬁced, and brains
he SN sectionswere co-immunostained with anti-OX-42 and anti-TonEBP (A), anti-OX-42
and anti-TonEBP antibodies (D), as indicated. Arrowheads show the expression of TonEBP
, TonEBP was detected in NeuN-positive cells, but not in GFAP-positive cells. At least four
30 μm. Shown are representative images from the ipsilateral (LPS, middle panels) or
tion. (E) Quantiﬁcation of the number of cells expressing TonEBP in SN sections injected
were presented as fold increase compared to the number of TonEBP+ cells in SN sections
2+ cells but not in NeuN+ cells. (F) Quantiﬁcation of ﬂuorescence intensity of TonEBP
ith anti-NeuN and anti-TonEBP antibodies and TonEBP signals were quantiﬁed in NeuN+
Fig. 2. TonEBP expression is increased in response to LPS treatment in primary cultures ofmicroglia. Primarymicrogliawere isolated frommesencephalon tissue of embryonic 14 day brain
and cultured, as described in the Materials and methods. (A) Representative image of microglia culture at DIV18, immunostained with anti-OX-42 and anti-GFAP antibodies. Typical
cultures contained few GFAP+ cells. At DIV 18, different doses of LPS were treated, as indicated, and cell lysates were subjected to Western blot analysis using anti-TonEBP, iNOS, or β-
actin antibodies. Note that LPS induced the expression of TonEBP as well as iNOS in microglia in a concentration-dependent fashion. Representative immunoblots (B) and
quantiﬁcation (C) from three independent experiments are shown. (C, D) Microglia were treated with LPS (10 μM) for different periods of time (0, 1, 3, 5, 18 h), as indicated. Cells
were ﬁxed and stained for TonEBP and OX-42. TonEBP expression was increased in both cytosol and nucleus after treatment of LPS. Shown are representative images (D) and
quantiﬁcation of TonEBP signals in the cytosol and nuclei (E) from three independent experiments. Scale bar, 50 μm. *p b 0.05, **p b 0.01, ***p b 0.001; one-way ANOVA, followed by
Newman–Keuls post-hoc test versus vehicle control.
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DMEM supplemented with 10% FBS. When the mixed cell cultures
reached conﬂuency in approximately 2–3 weeks post plating, microglia
were separated from the mixed primary culture by gentle shaking and
tapping of the ﬂasks. Detached cells were applied to a nylonmesh to re-
move astrocytes and microglia were then seeded as appropriate for
each experimental analysis (see below). Cells were grown inMEM sup-
plemented with 10% FBS. LPS was serially diluted in the medium before
treatment to minimize changes in osmolality. After 24 h, LPS wastreated, as indicated, and cells were subjected to Western blot analysis
or immunocytochemistry. For NaCl treatment, we added 25 μl of 25-
fold concentrated NaCl solution to 475 μl of culture media to increase
NaCl concentration to 75 mM.
2.7. Western blot analysis
Primarymicroglia were plated into 60mm culture plates pre-coated
with poly-D-lysine at a density of 5 × 105 cells/well. After treatment
Fig. 3. Analysis of immunomodulatory and osmomodulatory gene expression in response to LPS and NaCl treatment. Primary microglia were isolated from mesencephalon tissue of
embryonic 14 day brain and cultured, as described in the Materials and methods. At DIV 18, microglia were treated with LPS (10 μM, 8 h) or NaCl (75 mM, 4 h), as indicated, and were
subjected to qRT-PCR. mRNA levels of sodium/myoinositol cotransporter (smit) (A), sodium/chloride/betaine cotransporter (bgt-1) (B), interleukin-6 (il-6) (C), and tumor necrosis factor-
alpha (tnf-α) (D) were examined and normalized against the level of β-actin. Note that LPS increased mRNA levels of il-6 and tnf-α, but had no effect on smit and only marginally
increased bgt-1. *p b 0.05, **p b 0.01, ***p b 0.001; Student's t-test versus vehicle control.
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recombinant IL-4 (PeproTech, KR) at 24 h after plating, cells were
washed with PBS. Cell lysates were prepared by adding 1× SDS loading
buffer (60 mM Tris–HCl (pH 6.8), 25% glycerol, 2% SDS, 14.4 mM 2-
mercaptoethanol, 0.1% bromophenol blue), followed by vigorous shak-
ing and boiling. Protein extractswere separated by SDS-PAGE and trans-
ferred to a PVDF membrane (Millipore). The membrane was blocked
with 5% skim milk in TBS-T (10 mM Tri-HCl (pH 7.5), 10 mM NaCl,
0.1% Tween 20) for 1 h at room temperature and probed with the indi-
cated antibodies (TonEBP; (Miyakawa et al., 1999), 1/3000; iNOS (Santa
Cruz Biotechnology, Inc.), 1/1000; Actin, (Abcam), 1/5000). Signal was
developed with the Enhanced Chemiluminescence (ECL) detection sys-
tem (Millipore).
2.8. Immunocytochemistry
Primary microglia were plated onto 12 mm coverslips pre-coated
with poly-D-lysine at a density of 1 × 105 cells/coverslip. Cells were
ﬁxed with 4% paraformaldehyde, washed twice with 0.1% bovine
serum albumin (BSA) in PBS, and then permeabilized in 0.2% Triton X-
100 for 30min. To compare ﬂuorescence intensity all sections were im-
munostained side-by-side. Primary antibodies (rabbit anti-TonEBP,
1:1000; mouse anti-OX-42, 1:400, mouse anti-GFAP, 1:1500) were ap-
plied for 1 h at room temperature. After washing in 0.1% BSA/PBS, sec-
ondary antibodies (FITC-conjugated rabbit anti-rat IgG, 1:200; Texas
Red-conjugated donkey anti-goat IgG, 1:200) were applied for 1 h atFig. 4. LPS induces the expression of nitric oxide synthase 2 (nos2) and prostaglandin-
endoperoxide synthase 2 (ptgs2) in primary cultures of microglia. Primary microglia were
isolated from mesencephalon tissue of embryonic 14 day brain and cultured, as
described in the Materials and methods. At DIV 18, microglia were treated with LPS
(10 μM, 8 h), as indicated, and were subjected to qRT-PCR. mRNA levels of nitric oxide
synthase 2 (nos2) and prostaglandin-endoperoxide synthase 2 (ptgs2) were examined and
normalized against the level of β-actin. LPS induced mRNA levels of nos2 and ptgs2.
*p b 0.05, **p b 0.01; Student's t-test versus vehicle control.room temperature. After three times of washing in 0.1% BSA/PBS, cover-
slips were mounted with Vectashield medium (Vector Laboratories).
Samples were imaged by using an LSM 700 confocal laser scanning mi-
croscope (Carl Zeiss, Germany). To quantify ﬂuorescence intensity in
the cytosol and the nucleus in response to LPS treatment, all identiﬁable
cells from three independent experiments were photographed andFig. 5. TonEBP expression is increased in response to interleukin-4 and interferon-γ
treatment in primary cultures of microglia. Primary microglia were isolated from
mesencephalon tissue of embryonic 14 day brain and cultured, as described in the
Materials and methods. At DIV 18, various concentrations of recombinant rat
interleukin-4 (IL-4) and interferon-γ (IFN-γ) were treated, as indicated, and cell lysates
were subjected to Western blot analysis using anti-TonEBP and β-actin antibodies. Note
that IL-4 and IFN-γ induced the expression of TonEBP in microglia. Representative
immunoblots (A, B) and quantiﬁcation (C) from three independent experiments are
shown. *p b 0.05, **p b 0.01, ***p b 0.001; one-way ANOVA, followed by Newman–Keuls
post-hoc test versus vehicle control.
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tosol or nucleus, as indicated) was measured by using ImageJ software.2.9. RNA extraction and real-time quantitative PCR
Primary microglia were plated into 60 mm culture dish pre-coated
with poly-D-lysine at a density of 5 × 105 cells/dish. After treatment
27G.R. Jeong et al. / Journal of Neuroimmunology 295–296 (2016) 21–29with LPS (10 μM for 8 h) or NaCl (75mMfor 4 h), cells were prepared by
homogenization using TRIzol reagent (Invitrogen), phenol-chloroform
extraction (Junsei) and isopropanol precipitation (Merck millipore).
The RNA was reverse-transcribed to yield ﬁrst-strand cDNA using re-
verse transcriptase (Promega). The cDNA was mixed with pairs of
primers. The sequences for the forward and reverse primerswere as fol-
lows: rat interleukin-6 (il-6; 5′-TCCTACCCCAACTTCCAATGCTC-3′ and 5′-
TTGGATGGTCTTGGTCCTTAGCC-3′) and tumor necrosis factor-α (tnf-α;
5′-AAATGGGCTCCCTCTCATCAGTTC-3′ and 5′-TCTGCTTGGTGGTTTGCT
ACGAC-3′) and betaine-γ-amino-butyric acid transporter (bgt-1; 5′-
CCTCCATGGCCTGTGTACCGC-3′ and 5′-GAGTTCTTGCTTGACTGGAGAG-
3′), sodium dependent myo-inositol cotransporter (smit; 5′-TGAACACT
TCATTGGGCTGGTA-3′ and 5′-GAGCGGATGTAAATAGGGATGAAA-3′),
nitric oxide synthase2 (nos2; 5′-ACACAGTGTCGCTGGTTTGA-3′ and 5′-
AACTCTGCTGTTCTCCGTGG-3′), and prostaglandin-endoperoxide syn-
thase2 (ptgs2; 5′-TCACCCGAGGACTGGGCCAT-3′ and 5′-CAGCGAACCG
CAGGTGCTCA-3′). Step One Plus Real-Time PCR system (Life Technolo-
gies) was used for the quantiﬁcation.
2.10. Statistical analysis
Student's t-test or one-way analysis of variance (ANOVA) followed
by Newman–Keuls post-hoc test was used. Data represents mean ±
S.D. p b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. TonEBP expression is increased inmicroglia in a rodent model of neuro-
inﬂammation induced by LPS
On the basis of previous studies reporting the expression of TonEBP
in macrophages and other immune cells in peripheral tissues
(Berga-Bolanos et al., 2010; Buxade et al., 2012; Halterman et al.,
2012a), we have investigated whether TonEBP is expressed in resting
and activatedmicroglia. For this purpose,we performed stereotaxic sur-
gery and injected either LPS (5 μg in 3 μl of phosphate-buffered saline
(PBS)) or PBS (3 μl) into rat brain. LPS or PBS was stereotaxically deliv-
ered unilaterally into the SN, a region which was previously shown to
express a relatively high level of TonEBP (Maallem et al., 2006). Three
days after the injection, brains were removed, sectioned, and processed
for immunostaining. Microglial activation was conﬁrmed by the in-
crease in the number of OX-42-positive cells and morphological chang-
es of microglia (Fig. 1). Microglia in the LPS-injected ipsilateral side
transformed from a ramiﬁed to an activated form, whereas microglia
in the contralateral side of LPS injection or ipsilateral side of PBS injec-
tion exhibited ramiﬁedmorphologies, characteristic of restingmicroglia
(Fig. 1A). We observed that the expression of TonEBPwasmarkedly en-
hanced in OX-42-positive cells mainly in the nucleus speciﬁcally in the
ipsilateral side of LPS injection (Fig. 1A, E). We conﬁrmed that neither
the contralateral side of the LPS-injected brain nor the ipsilateral side
of the PBS-injected control brain showed TonEBP expression in OX-
42-positive cells (Fig. 1A, E). No signal was detected by immunostaining
with control immunoglobulin (Fig. 1B). Expression of TonEBP in neu-
rons and astrocytes has been reported in normal and kainic acid-
induced lesioned brain (Maallem et al., 2006; Shin et al., 2014). There-
fore, we examined if LPS induced any changes in the level or localization
of TonEBP in neurons and astrocytes by double-labeling with either
anti-NeuN or anti-GFAP antibodies and anti-TonEBP antibodies
(Fig. 1C–F). Consistent with previous reports, TonEBP was detected inFig. 6. Ischemic brain injury induced by middle cerebral artery occlusion (MCAo) results in To
described in the Materials and methods. Rats were divided into two groups (sham and MCAo
ischemia and brain sections including caudoputamen were used for the analysis (top box). TU
with anti-OX-42 and anti-TonEBP antibodies (B), anti-NeuN and anti-TonEBP antibodies (C), o
speciﬁcally in the nucleus of OX-42-positive cells. (E) Quantiﬁcation of OX-42+, NeuN+, or
TonEBP-expressing cells in each population (OX-42+, NeuN+, or GFAP+) was counted and no
ﬂuorescence intensity of TonEBP signal in NeuN+ cells. ***p b 0.001; Student's t-test versus conNeuN-positive cells in PBS-injected brain sections. In contrast with
OX-42+ cells, we found that LPS treatment did not alter the number of
TonEBP+/NeuN+ double-positive cells (Fig. 1C, E). However, LPS injec-
tion markedly increased the ﬂuorescence intensity of TonEBP signals
in NeuN-positive cells (Fig. 1C, F). In GFAP-positive cells, TonEBP was
barely detected in both PBS- and LPS-injected brain sections (Fig. 1D).
Together, these results suggest that LPS injection induces the expression
of TonEBP in microglia and neurons in rat brain, implying a role during
neuroinﬂammation.
3.2. LPS induces TonEBP expression in rat primary microglia
Peripheral macrophages are known to inﬁltrate into the CNS in the
condition of neuroinﬂammation. Histologically, CNS-resident microglia
and macrophages that inﬁltrated into the brain from peripheral tissues
cannot be distinguished, as both of these myeloid-origin cell types ex-
press common classic macrophage markers (Iba-1, OX-42, F4/80, and
Mac-1) (Carson et al., 2006). Thus, the OX-42-positive cells detected
in the LPS-injected brain can represent heterogeneous cell population
composed of both activated microglia and inﬁltrated macrophages. To
conﬁrm the expression of TonEBP in microglia, we isolated primary mi-
croglia from mesencephalon tissue of embryonic 14 day brain and con-
ﬁrmed that more than 95% of cells were OX-42-positive (Fig. 2A). In
primary cultures of microglia, LPS treatment increased the expression
of inducible nitric oxide synthase (iNOS) in a concentration-
dependentmanner, as expected. Importantly,we found that TonEBP ex-
pression was also induced by LPS treatment in a dose-dependent fash-
ion (Fig. 2B, C). When the cellular localization of TonEBP was
examined in primary microglia, faint expression of TonEBP was detect-
ed in the nucleus of cells treatedwith vehicle control. In response to LPS
treatment, TonEBP expression markedly increased in both the cytosol
and the nucleus (Fig. 2D, E). In the cytosol and nucleus, LPS induced
TonEBP expression within 1 h, which returned to basal level when ob-
served at 18 h after treatment. Taken together, results from both
in vivo and in vitro clearly show that LPS induces TonEBP expression in
microglia.
In the kidney, where osmolality rapidly ﬂuctuates, activation of
TonEBP induces the transcription of osmoprotective genes, such as sodi-
um/chloride/betaine cotransporter (bgt-1) (Miyakawa et al., 1998) and
sodium/myoinositol cotransporter (smit) (Miyakawa et al., 1999; Rim
et al., 1998), which play a role in increasing the concentration of intra-
cellular osmolytes and restoring osmotic balance. We thus examined if
LPS stimulation of microglia resulted in the induction of such
hyperosmotically stimulated genes (Fig. 3A–D). Results from quantita-
tive real time polymerase chain reaction (qRT-PCR) showed that in
striking contrast to the marked induction of smit by NaCl, treatment of
microglia with LPS failed to induce the expression of smit. Similarly,
LPS only marginally increased bgt-1 expression, in contrast to the dra-
matic induction triggered by NaCl. By contrast, LPS markedly induced
the expression of interleukin-6 (il-6) and tumor necrosis factor-alpha
(tnf-α), genes which were not induced by NaCl in microglia.
Previously, in macrophages, TonEBP has been shown to regulate the
expression of multiple toll-like receptor (TLR)-induced genes indepen-
dently of osmotic stress (Buxade et al., 2012). In particular, expression
of Nos2, Il6 and Ptgs2mRNAs in response to LPS was severely impaired
in macrophages lacking TonEBP. Consistent with the induction of TLR-
induced genes in macrophages (Buxade et al., 2012), LPS markedly in-
duced the expression of Il-6 (Fig. 3A),Nos2 and Ptgs2mRNAs inmicrog-
lia (Fig. 4A–C).nEBP expression in microglia. Focal cerebral ischemia was induced by transient MCAo, as
) and each group contained at least four animals. (A) Brains were dissected at 24 h after
NEL was examined at 24 h after MCAo (bottom). Brain sections were co-immunostained
r anti-GFAP and anti-TonEBP antibodies (D). Arrowheads show the expression of TonEBP
GFAP+ cells expressing TonEBP in sham and MCAo sections, as indicated. Number of
rmalized against the number in SN sections of the contralateral side. (F) Quantiﬁcation of
tralateral side of sham control.
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Our results suggest that conditions that induce neuroinﬂammation,
such as pathogen infection, trauma, stroke and brain injury, might reg-
ulate TonEBP expression inmicroglia. To investigate if inﬂammatory cy-
tokines control the expression of TonEBP, primary microglia were
treated with IFN-γ or IL-4 and the level of TonEBP was examined by
Western blot analysis. Similar to LPS treatment, both cytokines, IFN-γ
and IL-4 induced TonEBP expression in a dose-dependent fashion (Fig.
5A–C). To investigate if TonEBP expression is controlled by inﬂammato-
ry signals in vivo, we utilized the transient middle cerebral artery occlu-
sion (MCAo) model to induce ischemic brain injury. MCAo was
performed through 2 h of occlusion, followed by 24 h of reperfusion. Be-
fore examining the induction of TonEBP after MCAo, brain injury in in-
farcted areas was monitored through TUNEL staining to detect cell
death. As previously reported (Lee et al., 2012), damaged areaswere lo-
cated in caudoputamen (Fig. 6A).We observed that MCAomarkedly in-
duced the expression of TonEBP in OX-42-positive cells mainly in the
nucleus, speciﬁcally in the ipsilateral side (Fig. 6B). We conﬁrmed that
TonEBP expression was not detected in OX-42-positive cells the ipsilat-
eral side of the sham control brain (Fig. 6B). In sham control brain,
TonEBP was mostly, if not all, detected in NeuN+ cells, the level of
which was highly increased by MCAo (Fig. 6C). In GFAP+ cells, TonEBP
was undetected both in control and MCAo-lesioned brain (Fig. 6D). To-
gether, these results suggest that TonEBP is expressed primarily in neu-
rons, and inﬂammation induced by either LPS and MCAo triggers
TonEBP both in microglia and neurons.
4. Discussion
Increasing lines of evidence show that TonEBP is expressed in sever-
al isotonic tissues and suggest that tonicity-independent mechanisms
exist to regulate TonEBP expression and function (Halterman et al.,
2012b). In the brain, although the expression of TonEBP appears wide-
spread (predominantly detected in the nuclei of neurons and in a
minor population of astrocytes), expression in microglia has not been
reported to date (Loyher et al., 2004; Maallem et al., 2006). To the
best of our knowledge, the present study provides the ﬁrst evidence
that TonEBP expression is induced by several inﬂammatory stimuli in
microglia, the major cellular components which play crucial roles in
the regulation of innate immunity and inﬂammation in the CNS.
It is interesting to note that in striking contrast to the marked in-
crease of TonEBP in the brain in response to LPS and ischemic brain in-
jury as we report here, previous studies showed that hypertonicity
failed to induce TonEBP expression in microglia (Loyher et al., 2004;
Maallem et al., 2006). These results suggest that in microglia, changes
in tonicity are not a major regulator of TonEBP expression and TonEBP
might be regulated primarily by other pathways. Given that (i) LPS in-
duced the expression of TonEBP with little or subtle changes in the
levels of hyperosmotically stimulated genes (such as smit and bgt-1)
(Fig. 3) and that (ii) TonEBP expression was elevated by many other
proinﬂammatory signals both in vitro (Figs. 2 and 5) and in vivo
(Figs. 1 and 6), we favor the hypothesis that TonEBP expression in mi-
croglia is controlled by inﬂammatory signals in a tonicity-independent
fashion.
A recent study reported a tonicity-independent regulation of TonEBP
in the brain in a rodent model of seizure induced by kainic acid (Shin
et al., 2014). Notably, TonEBP expression was speciﬁcally elevated in
the nuclei of neurons, but not in microglia. Since kainic acid is well
known to induce neuroinﬂammation, it will be interesting to investigate
how TonEBP expression can be differentially regulated in speciﬁc cell
types by distinct inﬂammatory signals.
LPS is a well-known trigger for inﬂammation, and as such, LPS treat-
ment leads to the production of various kinds of pro-inﬂammatory cyto-
kines, reactive oxygen species (ROS), and nitric oxide in microglia.
However, the mechanism by which LPS controls the production ofsuch immunomodulators is not fully understood. In peripheral macro-
phages, it has been shown that LPS induces the expression of TonEBP
and that TonEBP, as a transcription factor, plays an essential part in
the induction of multiple immunomodulatory genes, such as tnf, il6,
and nos2 (iNOS) (Buxade et al., 2012). Importantly, such function of
TonEBP has been suggested to be independent of its osmomodulatory
role (Buxade et al., 2012; Kaltschmidt and Kaltschmidt, 2009; Kim
et al., 2013). In ﬁbroblast-like synoviocytes, proinﬂammatory cytokines,
TNF-α and IL-1β could induce the expression and nuclear localization of
TonEBP, processes which were also suggested to occur independent of
changes in tonicity (Yoon et al., 2011). Here we show that TonEBP is in-
duced by IL-4 and interferon-γ in microglia, suggesting that TonEBP
might be involved in M1 and M2 responses. More experiments will be
needed to examine if TonEBP is selectively or preferentially induced
by certain stimuli and how different cytokine environments control
TonEBP function. Thus, the expression and function of TonEBP appear
to be closely associated with inﬂammation both in the periphery
(Halterman et al., 2012a; Yoon et al., 2011) and in the brain (current
study), suggesting that inﬂammatory signalsmight represent important
physiological and pathophysiological stimuli that control TonEBP.
In summary, the present study demonstrates that in microglia, in-
ﬂammatory signals induce the expression of TonEBP both in the brain
and in culture. Future research will be necessary to investigate the
mechanism by which TonEBP expression is controlled in microglia in
pathological neuroinﬂammatory conditions, such as neurodegenerative
diseases, and more importantly, what role TonEBP plays during such
conditions.
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